Scientists have successfully treated two patients suffering from age-related macular degeneration (AMD), having their vision restored using a revolutionary stem cell treatment, according to a recent article in Russia Today.
As one of the leading causes of blindness in people aged 50 and above, AMD gradually reduces sight in sufferers, who experience blurred vision or in some cases loss of central vision. The new stem cell treatment works via a patch of engineered retinal pigment which is transplanted into the eyes. The subjects concerned exhibited significant vision improvement over a period of a year during which they were closely monitored.
“The therapies keep coming” comments Scott Wolf, President and Director of Research for Grace Century. Our portfolio project, Provia labs banks autologous cells and tissue. The thought that stem cells could save the quality of life to this degree is truly incredible.”
